of all car-t cell trials registered since 2001, more than half are being conducted in china.
.
.
.
.
.�this negligence must not be allowed to continue,� budkie�s letter states. �the university of california, berkeley, has clearly failed to follow federal regulations and guidelines.�
.
capgemini employees' rant on hike light up social media